Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha
about
sameAs
Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alphaHepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 geneHeat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanismsHepatocyte nuclear factor 1 is essential for transcription of sodium-dependent vitamin C transporter protein 1Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Bile formation and secretion.Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene.The SLCO (former SLC21) superfamily of transporters.Novel mechanism of impaired function of organic anion-transporting polypeptide 1B3 in human hepatocytes: post-translational regulation of OATP1B3 by protein kinase C activation.The expression of the solute carriers NTCP and OCT-1 is regulated by cholesterol in HepG2 cells.Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines.Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1Endocrine and paracrine role of bile acidsThe role of FXR in disorders of bile acid homeostasis.Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR imagesThe impact of cholesterol and its metabolites on drug metabolism.Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity.Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.Organic anion transporting polypeptides, cholestasis, and nuclear receptors.Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.Functional analysis of the rat bile salt export pump gene promoter.Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals.Hepatobiliary transporter expression in human hepatocellular carcinoma.Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions.Solute Carrier (SLC) Family TransportersNo significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid
P2860
Q28203512-CBFA3D48-DAA0-489B-99FD-159C8DD381A6Q28296115-6D6CBDCB-77CF-4CE4-9E36-40D44F8CA397Q28576055-72184770-6596-4181-931B-35BCE2EA8924Q33681069-624DB419-C239-4BC9-9A53-884FA72EBB26Q33714593-EB834F5A-888C-425A-B66E-524D52964C0AQ33881922-CF0CA8A3-AB9C-469E-8113-35D99296F9EDQ34287166-105CD062-DE5C-4853-9F61-D078BC42ED2FQ34333710-1FC0B1F0-EC98-4DAE-8205-723ED3A212DEQ34360004-B021FF21-EEC5-41B6-8448-46EBF90D307BQ34651864-FBDAD069-9F93-4234-ACC2-8BBCC9847CADQ34777362-A16808A6-DE6D-4E2C-A881-30A646696603Q36067365-65AF2A44-E3C1-438C-8B00-ECA7E4D84564Q36998199-04EF6A3C-58AF-46F9-9E83-76CE8B19A9A7Q37287593-3BE0C2D9-A5B0-40D5-A5CA-C584EBBD30C3Q37300843-8348DBE8-6981-4CE0-9235-766243253DC1Q37732370-BD6D52A5-F796-44D9-906B-CAE7B6C2EE55Q37841609-9877E28F-79F3-4CA0-854F-624D072B9EA0Q38644392-85AF188E-432D-4C10-B501-1BF8F145AB24Q39181492-C5A8ED13-BF0C-4358-BF44-42477A3160CBQ43899948-0FB5D05B-33ED-467F-80A5-2325D78D7C84Q44041187-FF87303A-5182-4649-B892-F921807D3DABQ44075225-A3129ED9-95A8-4185-9711-735AC4E51CE0Q46463048-62F41C06-7BD0-4891-BE8B-E2125CB4129AQ47325093-B28F3F05-39AE-4419-BB0D-BF4C994A2B26Q51328300-C5AA3488-9A99-452A-8929-B6E4B63EEF3DQ54674953-D749CC4E-B21F-47C7-AE60-9FF09ECBFED5Q55046512-D49E0A7B-1772-498C-94E1-314A652C09E2Q57684555-5A6FA39B-37D7-4981-8B64-48B74CC028DCQ57825120-06445D85-C2F9-40A5-BBE4-4B5820A29652
P2860
Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Characterization of the human ...... atocyte nuclear factor 1 alpha
@ast
Characterization of the human ...... atocyte nuclear factor 1 alpha
@en
Characterization of the human ...... atocyte nuclear factor 1 alpha
@nl
type
label
Characterization of the human ...... atocyte nuclear factor 1 alpha
@ast
Characterization of the human ...... atocyte nuclear factor 1 alpha
@en
Characterization of the human ...... atocyte nuclear factor 1 alpha
@nl
prefLabel
Characterization of the human ...... atocyte nuclear factor 1 alpha
@ast
Characterization of the human ...... atocyte nuclear factor 1 alpha
@en
Characterization of the human ...... atocyte nuclear factor 1 alpha
@nl
P2093
P2860
P3181
P356
P1476
Characterization of the human ...... atocyte nuclear factor 1 alpha
@en
P2093
B Hagenbuch
G A Kullak-Ublick
M Pontoglio
P2860
P304
P3181
P356
10.1074/JBC.M103988200
P407
P50
P577
2001-10-05T00:00:00Z